MedTrace Logo

Hepatitis B Prevalence in the Turkish Population Living in Middle Limburg

NCT03396458 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2020-01-27

No results posted yet for this study

Summary

This study will assess HBV (HBsAg, anti-HBc and anti-HBs) prevalence in the Turkish population living in Belgium. Additionally, the investigators will determine the risk factors for HBV infection and the uptake of screening, vaccination and antiviral treatment in this hard-to-reach Turkish population.

Conditions

Interventions

DIAGNOSTIC_TEST

Hepatitis B serology

A serum specimen will be taken and assessed for hepatitis B serology (HBsAg, anti-HBs and anti-HBc).

OTHER

Questionnaire

Participants will be asked to fill in a questionnaire regarding sociodemographic factors, migration history, risk factors for HBV infection (e.g. sharing toothbrushes, HBV infected family member) and HBV vaccination status.

Sponsors & Collaborators

  • Hasselt University

    lead OTHER

Principal Investigators

  • Geert Robaeys, M.D., Ph.D. · Hasselt University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2020-08-31
Completion
2020-08-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03396458 on ClinicalTrials.gov